4.7 Article

Enhanced Cell Growth of Adipocyte-Derived Mesenchymal Stem Cells Using Chemically-Defined Serum-Free Media

Journal

Publisher

MDPI
DOI: 10.3390/ijms18081779

Keywords

mesenchymal stem cell; multipotency; chemically-defined medium; proliferation; differentiation; secretome

Funding

  1. Industrial Technology Innovation Program through Ministry of Trade, Industry and Energy (MOTIE) [10063301]
  2. Bio and Medical Technology Development Program of the National Research Foundation (NRF)
  3. Korean Government [NRF-2012M3A9C6049719]

Ask authors/readers for more resources

The multipotency and anti-inflammatory effects of mesenchymal stem cells (MSCs) make them attractive for cell therapy in regenerative medicine. A large number of MSCs is required for efficient therapy owing to the low homing efficiency of MSCs to target sites. Furthermore, owing to limitations in obtaining sufficient amounts of MSCs, in vitro expansion of MSCs that preserves their differentiation and proliferative potential is essential. The animal factor included in culture media also limits clinical application. In this study, adipose-derived MSCs showed a significantly higher proliferation rate in STK2, a chemically-defined medium, than in DMEM/FBS. The expression of MSC surface markers was increased in the culture using STK2 compared to that using DMEM/FBS. Tri-lineage differentiation analyses showed that MSCs cultured in STK2 were superior to those cultured in DMEM/FBS. In addition, MSCs cultured in STK2 showed a reduced senescence rate, small and homogenous cell size, and were more genetically stable compared to those cultured in DMEM/FBS. Furthermore, secretome analysis showed that the expression of factors related to proliferation/migration, anti-inflammation, and differentiation were increased in STK2 culture medium compared to DMEM/FBS. Taken together, these results suggest that culture using STK2 medium offers many advantages through which it is possible to obtain safer, superior, and larger numbers of MSCs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis

Kyungsoo Jung, Joon-Seok Choi, Beom-Mo Koo, Yu Jin Kim, Ji-Young Song, Minjung Sung, Eun Sol Chang, Ka-Won Noh, Sungbin An, Mi-Sook Lee, Kyoung Song, Hannah Lee, Ryong Nam Kim, Young Kee Shin, Doo-Yi Oh, Yoon-La Choi

Summary: This study explored new biomarkers using outlier analysis and identified two genes (TM4SF4 and LRRK2) as potential targets for lung and breast cancer. The knockdown of these genes suppressed cancer cell growth and LRRK2-overexpressing cell lines showed increased sensitivity to LRRK2-IN-1, indicating their therapeutic potential.

CANCER RESEARCH AND TREATMENT (2021)

Article Medicine, Research & Experimental

RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse

Jaebeom Cho, Hye-Young Min, Ho Jin Lee, Seung Yeob Hyun, Jeong Yeon Sim, Myungkyung Noh, Su Jung Hwang, Shin-Hyung Park, Hye-Jin Boo, Hyo-Jong Lee, Sungyoul Hong, Rang-Woon Park, Young Kee Shin, Mien-Chie Hung, Ho-Young Lee

Summary: Slow-cycling/dormant cancer cells play crucial roles in cancer relapse and drug resistance. A specific subpopulation of SCCs in NSCLC has been identified, showing dormancy-like phenotypes and high survival capacity through upregulation of RGS2. RGS2 induces translational arrest in SCCs via eIF2 alpha phosphorylation, which can be reversed by RGS2 antagonism or phosphodiesterase S inhibitors, leading to apoptosis. Combining low-dose chemotherapy with translation-promoting pharmacological intervention is an effective strategy to prevent tumor progression in NSCLC patients after rigorous chemotherapy.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Multidisciplinary Sciences

A novel immune prognostic index for stratification of high-risk patients with early breast cancer

Hannah Lee, Mi Jeong Kwon, Beom-Mo Koo, Hee Geon Park, Jinil Han, Young Kee Shin

Summary: Using public gene expression microarray datasets, researchers classified breast cancer patients into different risk groups based on clinical and proliferation risk, and developed an immune prognostic index for predicting recurrence risk. This index was found to be an independent prognostic factor for disease-free survival or distant metastasis-free survival and outperformed clinicopathological variables in predicting prognosis. The immune prognostic index can identify low-risk patients among those classified as clinically and proliferation high-risk, regardless of the molecular subtype of breast cancer, potentially overcoming limitations of current multigene assays.

SCIENTIFIC REPORTS (2021)

Article Oncology

A novel anti-c-Kit antibody-drug conjugate to treat wild-type and activating-mutant c-Kit-positive tumors

Jin-Ock Kim, Kwang-Hyeok Kim, Eun Ji Baek, Bomi Park, Min Kyung So, Byoung Joon Ko, Han-Jik Ko, Sang Gyu Park

Summary: The study developed an anti-c-Kit antibody-drug conjugate, NN2101-DM1, which showed potent growth-inhibitory activities against c-Kit-positive cancer cell lines, especially in cases of TKI resistance. In mouse xenograft models, NN2101-DM1 exhibited strong growth-inhibitory activities against imatinib-resistant GIST and SM cells, and a significantly higher anti-cancer effect than carboplatin/etoposide against SCLC cells. Combination of NN2101-DM1 with imatinib in imatinib-sensitive GIST cells induced complete remission in mouse xenograft models, suggesting its potential as a therapeutic agent for wild-type and mutant c-Kit-positive cancers.

MOLECULAR ONCOLOGY (2022)

Article Pharmacology & Pharmacy

A Fully Human Monoclonal Antibody Targeting cKIT Is a Potent Inhibitor of Pathological Choroidal Neovascularization in Mice

Songyi Seo, Koung Li Kim, Yeongju Yeo, Ryul- Kim, Hayoung Jeong, Jin-Ock Kim, Sun-Hwa Song, Mi-Jin An, Jung-Woong Kim, Hye Kyoung Hong, Min Hee Ham, Se Joon Woo, Jong-Hyuk Sung, Sang Gyu Park, Wonhee Suh

Summary: The study demonstrated that the fully human monoclonal antibody NN2101 can effectively treat neovascular AMD by inhibiting the SCF/cKIT signaling pathway, with efficacy comparable to the VEGF inhibitor aflibercept. Combined use of NN2101 and aflibercept showed additive therapeutic effects on CNV, without causing ocular toxicity or interfering with early retinal vascular development in mice. Ocular pharmacokinetic analysis in rabbits confirmed NN2101's suitability for intravitreal injection.

PHARMACEUTICS (2021)

Article Biotechnology & Applied Microbiology

A multipathogen DNA vaccine elicits protective immune responses against two class A bioterrorism agents, anthrax and botulism

Na Young Kim, Won Rak Son, Min Hoon Lee, Hong Seok Choi, Jun Young Choi, Young Jo Song, Chi Ho Yu, Dong Hyun Song, Gyeung Haeng Hur, Seong Tae Jeong, Sung Youl Hong, Young Kee Shin, Sungho Shin

Summary: This study developed a synthetic dual-pathogen DNA vaccine for anthrax and botulism, which elicited high levels of antibody response and provided over 50% protection against both pathogens. The study suggests a prospective approach for developing emergency vaccines that can be distributed on a massive scale in response to biothreat emergencies or infectious disease outbreaks.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2022)

Article Dermatology

IL-6R/Signal Transducer and Activator of Transcription 3 Signaling in Keratinocytes rather than in T Cells Induces Psoriasis-Like Dermatitis in Mice

Advaitaa Ravipati, Sabrina Nolan, Martin Alphonse, Dustin Dikeman, Christine Youn, Yu Wang, Nicholas Orlando, Garrett Patrick, Steven Lee, Roger Ortines, Haiyun Liu, Robert J. Miller, Carly A. Dillen, Mark Marchitto, S. Sarah Cai, Lloyd S. Miller, Nathan K. Archer

Summary: Signal transducer and activator of transcription 3 (STAT3) plays an important role in the pathogenesis of psoriasis. This study found that STAT3 signaling in keratinocytes is more important than in T cells for the development of psoriasis-like dermatitis. The mechanism involves upstream IL-6R signaling in keratinocytes and downstream inhibition of type 1 immunity-associated CXCL10 responses.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Medicine, Research & Experimental

Matrix metalloproteinase 11 (MMP11) in macrophages promotes the migration of HER2-positive breast cancer cells and monocyte recruitment through CCL2-CCR2 signaling

Shin Ung Kang, Soo Youn Cho, Hyojin Jeong, Jinil Han, Ha Yeong Chae, Hobin Yang, Chang Ohk Sung, Yoon-La Choi, Young Kee Shin, Mi Jeong Kwon

Summary: The study demonstrated that MMP11 expression in mononuclear inflammatory cells, predominantly macrophages, is an independent negative prognostic factor in breast cancer. Furthermore, MMP11-overexpressing macrophages promote migration of HER2-positive breast cancer cells and monocyte recruitment through CCL2-CCR2 signaling, suggesting a pro-tumoral role of MMP11 in macrophages in HER2-positive breast cancer through interaction with cancer cells and other cells in the tumor microenvironment.

LABORATORY INVESTIGATION (2022)

Article Anesthesiology

Anoctamin 1/TMEM16A in pruritoceptors is essential for Mas-related G protein receptor-dependent itch

Hyesu Kim, Hyungsup Kim, Hawon Cho, Byeongjun Lee, Huan-Jun Lu, Kyungmin Kim, Sooyoung Chung, Won-Sik Shim, Young Kee Shin, Xinzhong Dong, John N. Wood, Uhtaek Oh

Summary: Research has found that ANO1 is a transduction channel mediating Mrgpr-dependent itch signals. Genetic ablation of ANO1 in dorsal root ganglion neurons significantly reduces scratching behaviors in response to acute and chronic Mrgpr-dependent itch models and epidermal hyperplasia induced by dry skin. Overexpression of ANO1 in ANO1-deficient mice rescues the impaired itching observed in these mice.
Article Chemistry, Medicinal

Relevance of Circulating Tumor Cells as Predictive Markers for Cancer Incidence and Relapse

Chaithanya Chelakkot, Hobin Yang, Young Kee Shin

Summary: Shedding cancer cells from the primary site or bone marrow into the circulatory system and their subsequent formation of secondary metastatic lesions is a key feature of invasive cancers. Circulating tumor cells (CTCs), found either as single cells or clusters, carry valuable information and have the potential to predict cancer prognosis, progression, and guide tailored therapies.

PHARMACEUTICALS (2022)

Article Biochemistry & Molecular Biology

Antibody-Drug Conjugate Targeting c-Kit for the Treatment of Small Cell Lung Cancer

Kwang-Hyeok Kim, Jin-Ock Kim, Jeong-Yang Park, Min-Duk Seo, Sang Gyu Park

Summary: Lung cancer is a major cause of cancer-related deaths, with small cell lung cancer (SCLC) accounting for a significant portion. Overexpression of c-Kit is a characteristic of SCLC. This study found that the antibody-drug conjugate 4C9-DM1 shows potential as a therapeutic agent for SCLC, as it efficiently induces apoptosis and inhibits tumor growth. Combination treatment with other drugs further enhances its anti-tumor effects.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Immunology

Keratinocyte-derived defensins activate neutrophil-specific receptors Mrgpra2a/b to prevent skin dysbiosis and bacterial infection

Xintong Dong, Nathachit Limjunyawong, Elizabeth Sypek, Gaofeng Wang, Roger Ortines, Christine Youn, Martin P. Alphonse, Dustin Dikeman, Yu Wang, Mark Lay, Ruchita Kothari, Chirag Vasavda, Priyanka Pundir, Loyal Goff, Lloyd S. Miller, Wuyuan Lu, Luis A. Garza, Brian S. Kim, Nathan K. Archer, Xinzhong Dong

Summary: The signaling pathway between epithelial cells and neutrophils is crucial for maintaining healthy skin ecology and promoting antibacterial host defense. Defensins and Mrgpra2 play critical roles in combating infections and maintaining microbial homeostasis.

IMMUNITY (2022)

Article Dermatology

Crisaborole efficacy in murine models of skin inflammation and Staphylococcus aureus infection

Christine Youn, Dustin A. Dikeman, Evelyn Chang, Haiyun Liu, Sabrina J. Nolan, Martin P. Alphonse, Daniel P. Joyce, Qi Liu, James Meixiong, Xinzhong Dong, Lloyd S. Miller, Nathan K. Archer

Summary: Phosphodiesterase 4 (PDE4) is highly expressed in keratinocytes and immune cells, promoting pro-inflammatory responses. PDE4 inhibitors such as crisaborole have been approved for the treatment of inflammatory skin diseases, but their immunopathogenetic effects are not fully understood.

EXPERIMENTAL DERMATOLOGY (2023)

Review Biochemistry & Molecular Biology

Modulating Glycolysis to Improve Cancer Therapy

Chaithanya Chelakkot, Vipin Shankar Chelakkot, Youngkee Shin, Kyoung Song

Summary: Cancer cells undergo metabolic reprogramming to adopt a glycolysis-dominant metabolic profile, providing them with a survival advantage and contributing to a pro-cancerous tumor environment. This metabolic switch also leads to increased resistance to chemotherapy and radiation. Immune cells in the tumor microenvironment also exhibit a similar metabolic shift, leading to competition with cancer cells for nutrients. Targeting enhanced glycolysis in cancer cells has shown promise in improving treatment efficacy, but effective strategies are still lacking. This review highlights the importance of metabolic reprogramming in cancer cells and the potential of targeting it to enhance conventional cancer therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

SMAD4 Controls Cancer Cell Metabolism by Regulating Methylmalonic Aciduria Cobalamin Deficiency (cbl) B Type

Kyoung Song, Hun Seok Lee, Lina Jia, Chaithanya Chelakkot, Nirmal Rajasekaran, Young Kee Shin

Summary: SMAD4 is a critical signaling mediator that regulates various cellular functions. This study confirms the interaction between SMAD4 and MMAB and reveals that SMAD4 controls cancer cell metabolism by regulating MMAB expression. Knockdown of MMAB affects cancer cell metabolism and induces apoptosis.

MOLECULES AND CELLS (2022)

No Data Available